Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol versus formoterol + budesonide in repeated low-dose allergen challenge in mild allergic asthma
2004-000211-26Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of budesonide and formoterol in asthma and allergic asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Change in PD20 methacholine. Started Jul 2004; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2004-000211-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000211-26.